LUMEXA IMAGING HOLDINGS INC (LMRI)
Health Care · Outpatient diagnostic imaging and radiology services · NASDAQ
Lumexa is a leading national provider of outpatient diagnostic imaging services and radiologist interpretation with 188 imaging centers across 13 states, generating revenue from patient imaging, radiologist services, and management fees.
What LUMEXA IMAGING HOLDINGS INC does
Lumexa Imaging is one of the largest national providers of diagnostic imaging services in the United States, operating 188 outpatient imaging centers across 13 states with integrated radiology services. The company generates revenue primarily from patient imaging studies and radiologist interpretations, as well as from management fees for operating unconsolidated centers and providing radiology support to third-party hospitals. As of December 31, 2025, Lumexa consolidated 102 centers and accounted for 86 centers under the equity method, maintaining strategic joint venture partnerships with health systems.
Themes: Diagnostic imaging / radiology, Outpatient healthcare services, Advanced imaging (MRI/CT), Health system partnerships
Fundamentals
- Price$11.85 as of 2026-08-24 close
- Market cap$1.1B as of 2026-08-24
- P/En/a negative earnings
- Net margin-3.6% as of 2026-08-24
- Gross margin+15.1% as of 2026-08-24
- ROE-8.0% as of 2026-08-24
- Debt / equity1.47 as of 2026-08-24
- Revenue growth (YoY)+8.0% as of 2026-08-24
- Beta2.01 as of 2026-08-24
- Last reported earnings2026-08-12 SEC EDGAR Form 8-K (Item 2.02)
How LMRI compares in its sector
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- gross marginbottom 10% 384 covered Health Care peers, as of 2026-08-24
- return on equitymiddle range 576 covered Health Care peers, as of 2026-08-24
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How LUMEXA IMAGING HOLDINGS INC looks technically
LUMEXA IMAGING HOLDINGS INC (LMRI): a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 26, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 55, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 2 trading days ago. Trading volume is unusually light — only about 43% of its 30-day average.
Trend
7
| Distance from the 200-day | not enough price history yet — needs 200 trading sessions | n/a |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $11.14 | $11.14 |
| 200-day moving average | not enough price history yet — needs 200 trading sessions | n/a |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 11 calendar days ago — the swings before that are what the structure reading is measured on | 11 sessions |
| Since the 50/200 cross | not enough price history yet — needs 200 trading sessions | n/a |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 26, with buyers in control | 25.8 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 55, neither overbought (above 70) nor oversold (below 30) | 54.8 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($11.17 to $13.00) — its "stochastic" reading is 37 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 37.2 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 13 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $19.45 | $19.45 |
|---|---|---|
| From the 52-week high | it is 39.1% below its 52-week high (its highest price of the past year) | -39.1% |
| Above the 52-week low | it is 83.7% above its 52-week low (its lowest price of the past year) | +83.7% |
| Below the 52-week high | it is 39.1% below its highest point of the past year | 39.1% |
| Since a 20-day breakout | it made a new 20-day high about 2 trading days ago | 2 sessions |
| Since a 55-day breakout | it made a new 55-day high about 36 trading days ago | 36 sessions |
| All-time high | its highest closing price on record is $19.45 (set on 2025-12-15) | $19.45 |
| Given back of the 52-week move | not available for this company yet | n/a |
| From the all-time high | it is 39.1% below its all-time high | -39.1% |
| Nearest price level | not enough price history yet — needs 252 trading sessions | n/a |
| All-time low | its lowest closing price on record is $6.45 (set on 2026-05-15) | $6.45 |
| Above the all-time low | it is 83.7% above its all-time low | +83.7% |
Volatility
4
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 78% of it) | 22nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.7085 between its high and its low — about 6.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.7085 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $10.31 and $12.67 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $10.31 – $11.49 – $12.67 |
| Typical daily range (% of price) | its price moves about 6.0% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 6.0% |
Volume
1
| Volume vs its 30-day average | trading volume is unusually light — only about 43% of its 30-day average | 0.43× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 1.7% since the prior reading | -1.6% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 2 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 2 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-24 0.2% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.2% |
|---|---|---|
| Open gap | it gapped 2.1% above the previous close 52 sessions ago and has not traded back through the level it left behind at 8 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.1% |
| Gap filled | a 2.2% gap up opened on 2026-08-19 has been "filled" 3 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 3 sessions ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 5.1 percentage points (the stock gained 8.4% while the market gained 3.3%) | +5.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 45.7 percentage points (the stock gained 48.1% while the market gained 2.4%) | +45.7% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 28.7 percentage points (the stock lost 17.7% while the market gained 11.1%) | -28.7% |
| vs market, 12 months | not available for this company yet | n/a |
Signal agreement
2
| Bullish technical signals | 4 of the 7 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a fresh 20-day high, MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 7 |
|---|---|---|
| Bearish technical signals | 1 of the 7 technical signals we can compute for it is currently in a bearish state: lagging the market over 6 months — these describe past price behaviour, not a forecast | 1 of 7 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 5.8% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-17 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thick, spanning 12.8% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | +5.8% |
|---|
Volume-weighted price
1
| Vs this year’s average price paid | the price is 7% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $11.10 — a volume-weighted average of daily closes over 151 sessions, not a true tick-by-tick VWAP. | +6.7% |
|---|
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-24.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Broke out to a new 20-day high · in a strong, established uptrend (ADX) · Analyst price target recently CUT · Trading above the Ichimoku cloud | Learn: adx · rsi · breakout · volume and relative volume
Based on daily closing prices as of 2026-08-24. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.25 mean, 1=Strong Buy…5=Strong Sell) — 7 analysts
- Mean price target$17.00 range $9.00 – $23.00
Analyst estimates, as of 2026-08-22. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for LMRI
- Consensus EPS estimate$0.1859 next reporting period, as of 2026-08-22
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on physician referrals from unaffiliated healthcare providers; failure to maintain or increase referrals could materially impact revenues","Significant debt burden ($830.4 million in current and long-term debt as of Q1 2026) with limited profitability (net margin -3.56%), creating refinancing and leverage risks","High capital intensity of imaging center operations and competition for market share in geographically concentrated footprint"]
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
- Last 180 days2 buys ($476863) · 0 sells — 2 buying insiders
Most recent open-market transaction: 2026-05-19. As of 2026-08-25.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about LMRI's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding LMRI as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 3,444,072
- Reported value $29,619,019
reported quarterly holdings change (2025-12-31 → 2026-03-31): 2 new, 2 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
LMRI had 2,761,182 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
LMRI had 2.87% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 8.53 days to cover at the same settlement.
- Reported short interest (shares) 2,761,182
- Short interest (% of shares outstanding) 2.87%
- Prior settlement (shares) 2,522,541
- Reported change 9.46%
- Days to cover (reported) 8.53
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- RadiologyMD
- American Imaging Management Services
- Patients' Imaging Centers
- Barlow Respiratory Hospital radiology divisions
- Regional hospital-owned imaging departments
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Frequently asked questions
What does LUMEXA IMAGING HOLDINGS INC (LMRI) do?
Lumexa Imaging is one of the largest national providers of diagnostic imaging services in the United States, operating 188 outpatient imaging centers across 13 states with integrated radiology services. The company generates revenue primarily from patient imaging studies and radiologist interpretations, as well as from management fees for operating unconsolidated centers and providing radiology support to third-party hospitals.
What sector is LUMEXA IMAGING HOLDINGS INC (LMRI) in?
LUMEXA IMAGING HOLDINGS INC (LMRI) is classified in the Health Care sector. Its industry is Outpatient diagnostic imaging and radiology services. It trades on NASDAQ.
Who are LUMEXA IMAGING HOLDINGS INC's (LMRI) competitors?
Notable peers of LUMEXA IMAGING HOLDINGS INC (LMRI) include RadiologyMD, American Imaging Management Services, Patients' Imaging Centers, Barlow Respiratory Hospital radiology divisions and Regional hospital-owned imaging departments. This peer set is informational only — not financial advice.
Is LUMEXA IMAGING HOLDINGS INC (LMRI) overbought or oversold right now?
LUMEXA IMAGING HOLDINGS INC (LMRI) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 55, in the neutral middle (as of 2026-08-24). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on LMRI come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.